A study from the University of Michigan Health Rogel Cancer Center may have—at last—cracked the cold case of immunotherapy ...

TERN-701 showed promising early results, with significant molecular responses and a strong safety profile in heavily ...

Melioidosis—a bacterial infection that causes fever, pneumonia, and sepsis—presents two enormous challenges for infectious ...

MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung ...

Recent research has unveiled that DNA secreted by tumor cells through extracellular vesicles (EVs) can stimulate an immune response that helps inhibit the spread of tumors to the liver. This ...

Ferring activates first sites in a three-arm study of ADSTILADRIN as a monotherapy or in combination with chemotherapy or an ...

Prof. Daugaard will deliver a podium presentation highlighting Rakovina Therapeutics’ research and the Company’s product development pipeline, followed by examples of various model systems used by the ...

Hutchmed China and its partner Innovent Biologics announced conditional approval from China’s National Medical Products ...

Purple Biotech PPBT, a clinical-stage oncology company, reported positive final results from the mid-stage study of its lead ...

Targeted Oncology co-hosts Kristie L. Kahl and Andrew Svonavec highlight abstracts for community oncologists to look out for ...

A study from the University of Michigan Health Rogel Cancer Center may have, at last, cracked the cold case of immunotherapy resistance.The research ...

The table below is a review of notable updates that occurred in November 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.